Brief: Mirati Stockholders Voted 'For' Proposal To Adopt Deal Between Co, Bristol-Myers Squibb
13/12/2023 22:34
Dec 13 (Reuters) - Mirati Therapeutics Inc MRTX.O :
* MIRATI THERAPEUTICS- ON DEC 13 AT SPECIAL MEETING OF
STOCKHOLDERS, STOCKHOLDERS VOTED 'FOR' PROPOSAL TO ADOPT DEAL
BETWEEN CO, BRISTOL-MYERS SQUIBB
Further company coverage: MRTX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Mirati Therapeutics
See all newsBrief: European Commission Approves KRAZATI As A Targeted Treatment For Non-Small Cell Lung Cancer
US FDA turns down Amgen lung cancer drug Lumakras for full approval (updated)
US FDA turns down Amgen lung cancer drug Lumakras for full approval
Brief: Mirati Stockholders Voted 'For' Proposal To Adopt Deal Between Co, Bristol-Myers Squibb
Mirati's lung cancer drug gets EU's regulatory backing (updated)